| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/15/2004 | WO2004004833A1 Use of cyclooxygenase-2 selective inhibitors and thrombolytic agents for the treatment or prevention of a vaso-occlusive event |
| 01/15/2004 | WO2004004778A1 Use of cetp inhibitors and optionally hmg coa reductable inhibitors and/or antihypertensive agents |
| 01/15/2004 | WO2004004777A1 Use of cetp inhibitors and antihypertensive agents as well as optionally hmg coa reductase inhibitors |
| 01/15/2004 | WO2004004776A1 Phamaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor |
| 01/15/2004 | WO2004004775A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 01/15/2004 | WO2004004774A2 Compositions comprising panthetine for the treatment of dyslipidemia |
| 01/15/2004 | WO2004004773A1 Remedies for respiratory diseases |
| 01/15/2004 | WO2004004772A1 Remedy for diabetes |
| 01/15/2004 | WO2004004763A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 01/15/2004 | WO2004004757A1 Treatment for eye disorder |
| 01/15/2004 | WO2004004754A1 Novel medicament combinations based on magnesium salts and fibrinolytics |
| 01/15/2004 | WO2004004750A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 01/15/2004 | WO2004004738A1 Remedy or preventive for keratoconjunctival epithelial cell injury |
| 01/15/2004 | WO2004004733A1 7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrrolo[2,1-b]-quinazolinone derivatives |
| 01/15/2004 | WO2004004725A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | WO2004004724A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | WO2004004723A1 Novel medicament combinations based on sodium channel blockers and magnesium salts |
| 01/15/2004 | WO2004004722A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(nk-1) antagonists for the treatment of emesis, depression, anxiety and cough |
| 01/15/2004 | WO2004004712A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | WO2004004708A1 A pharmaceutical composition useful for treating chronic myeloid leukemia |
| 01/15/2004 | WO2004004705A2 Pharmaceutical formulations for preparing drink products |
| 01/15/2004 | WO2004004704A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 01/15/2004 | WO2004004702A2 Method to inhibit ischemia and reperfusion injury |
| 01/15/2004 | WO2004004699A2 Use of dantrolene, a ryanodine antagonist, in treating neural injury |
| 01/15/2004 | WO2004004698A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | WO2004004694A1 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 01/15/2004 | WO2004004690A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | WO2004004689A1 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/15/2004 | WO2004004686A2 Cartilage enhancing food supplements and methods of preparing the same |
| 01/15/2004 | WO2004004665A2 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 01/15/2004 | WO2004004661A2 Boroproline compound combination therapy |
| 01/15/2004 | WO2004004658A2 Methods and compositions relating to isoleucine boroproline compounds |
| 01/15/2004 | WO2004004656A2 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | WO2004004653A2 Methods for treating psychosis associated with interferon-alpha therapy |
| 01/15/2004 | WO2004004652A2 Mitotic kinesin binding site |
| 01/15/2004 | WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 01/15/2004 | WO2004004644A2 Combination of mtor inhibitor and a tyrosine kinase inhibitor for the treatment of neoplasms |
| 01/15/2004 | WO2004004641A2 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPα SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDS |
| 01/15/2004 | WO2004004640A2 Methods, compositions and kits for treating damage to excitable tissue |
| 01/15/2004 | WO2004004633A2 Use of tnfalpha antibodies and another drug |
| 01/15/2004 | WO2004004483A1 Vitamin-containing system for stabilising the immune response of animals |
| 01/15/2004 | WO2004004451A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | WO2003088920A8 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/15/2004 | WO2003082216A3 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/15/2004 | WO2003082191A3 Substituted 2,3-diphenyl pyridines |
| 01/15/2004 | WO2003080794A3 Inhibition of rna function by delivery of inhibitors to animal cells |
| 01/15/2004 | WO2003080118A3 Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 01/15/2004 | WO2003079969A3 Compositions and methods for treating and preventing necrosis |
| 01/15/2004 | WO2003068936A3 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds |
| 01/15/2004 | WO2003061587A3 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 01/15/2004 | WO2003059274A3 Vitamin formulation for cardiovascular health |
| 01/15/2004 | WO2003049697A3 Treatment of glioblastoma with thymosin-alpha 1 |
| 01/15/2004 | WO2003049682A3 Composition and method for treating chronic allograft rejection |
| 01/15/2004 | WO2003039466A3 Method of treating estrogen responsive breast cancer |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003019146A3 High throughput screening assays using fatty acid synthetic enzymes |
| 01/15/2004 | WO2003006059A9 Vegfr-1 antibodies to treat breast cancer |
| 01/15/2004 | WO2002092854A3 Genes expressed in breast cancer as prognostic and therapeutic targets |
| 01/15/2004 | WO2002085342A3 Use of nsaids for prevention and treatment of cellular abnormalities of the lung or bronchial pathway |
| 01/15/2004 | WO2002072010A3 Taxane prodrugs |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | WO2002015896A3 Methods and compositions for potentiating antibiotic action against persistent/tolerant pathogenic microorganisms |
| 01/15/2004 | US20040010813 Comprises nucleotide sequences capable of heart specific transcription for treating cardiomyopathies and cardiovascular disorders; anticardiopathic agents; drug screening |
| 01/15/2004 | US20040010218 Injecting an aberrant tissue-selective photosensitizer into the bloodstream, exposing the aberrant tissue to light to activate the photosensitizer which increases the permeablitiy of the vasculature; injecting a chemotherapeutic agent |
| 01/15/2004 | US20040010215 Silver-containing compositions, devices and methods for making |
| 01/15/2004 | US20040010047 Synergistic mixture of anticholesterol agents and coenzyme Q-10 |
| 01/15/2004 | US20040010044 Synergistic mixture of paracetamol, niflumic acid and excipients |
| 01/15/2004 | US20040010027 Tumor angiogenesis and metastasis inhibition. |
| 01/15/2004 | US20040010013 Cannabinoid receptor ligands |
| 01/15/2004 | US20040010008 Piperidine derivatives useful as CCR5 antagonists |
| 01/15/2004 | US20040010003 9,9-dimethyl-3-oxa-9-azoniumtricyclo(3.3.1.0(2,4))nonanyl 2,2-diphenylpropionate quaternary salt |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040010001 Methods and compositions for modulating cell proliferation and cell death |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009980 Calcilytic compounds |
| 01/15/2004 | US20040009968 Indazole compounds useful as protein kinase inhibitors |
| 01/15/2004 | US20040009961 Composition and therapies for hyperlipidaemia-associated disorders |
| 01/15/2004 | US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias. |
| 01/15/2004 | US20040009927 Administering a control agent which inhibits the interaction of cAMP and CRP or inhibits cAMP synthesis or enhancing biofilm formation by administering cAMP or a cAMP analogue which enhances the interaction of cAMP and CRP. |
| 01/15/2004 | US20040009914 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009906 Induction of antigen specific immunologic tolerance |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |
| 01/15/2004 | US20040009895 Also stimulating interleukin-18 or GM-CSF by administering lactoferrin |
| 01/15/2004 | US20040009243 Solvent extraction; plant extracts; for use in food and drugs |
| 01/15/2004 | US20040009237 Copper lowering treatment of inflammatory and fibrotic diseases |
| 01/15/2004 | US20040009236 Bowel cleansing composition |
| 01/15/2004 | US20040009235 Hydroxyapatite with specified particle size and a pharmaceutical carrier; osteoporosis; calcium deficiency |
| 01/15/2004 | US20040009234 Gastrointestinal compositions |
| 01/15/2004 | US20040009222 Processes for forming a drug delivery device |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |
| 01/15/2004 | US20040009214 An antianxiety agent such as buspirone; a dermal penetration enhancer of given formula such as octyl salicylate; and a volatile liquid such as ethanol |
| 01/15/2004 | US20040009213 Water-based delivery systems |
| 01/15/2004 | US20040009169 Administration of agents for the treatment of inflammation |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009160 Bioactive food complex, method for making bioactive food complex product and method for controlling disease |
| 01/15/2004 | US20040009156 Synergistic mixtures comprising drugs such as cisplatin and cytoplasmic motor proteins, used as anticarcinogenic agents |
| 01/15/2004 | US20040009147 Administering mixtures of antibodies and tumor necrosis factors, immunosuppressants, antibiotics, antiinflammatory agents, cytokines, angiogenesis inhibitors or fibroblast growth factors; prophylaxis of graft versus host disease |
| 01/15/2004 | US20040009126 Inhalation system for prevention and treatment of intracellular infections |
| 01/15/2004 | DE10328272A1 Medikament mit Xenon und NO Medicine with xenon and NO |